Frontlight ResearchEarly access
Trial site
Hemophilia Center of Western Pennsylvania
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Haemophilia7 trials
- Sickle cell disease1 trial
- Thalassaemia1 trial
- Phase
- Phase 1/22 trials
- Phase 21 trial
- Phase 31 trial
- Phase 41 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- Spark Therapeutics, Inc.2 trials
- American Thrombosis and Hemostasis Network1 trial
- BioMarin Pharmaceutical1 trial
- Margaret Ragni1 trial
- Regeneron Pharmaceuticals1 trial
- and 1 more
Running trials
Recruiting
Enrolling by invitation
Active, not recruiting
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Active, not recruiting
Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Haemophilia3 recruiting
- Sickle cell disease1 recruiting
- Thalassaemia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026